Antibody engineering promotes nanomedicine for cancer treatment.
Gao
Jie
J
Feng
Si-Shen
SS
Guo
Yajun
Y
D000818:Animals; D000911:Antibodies, Monoclonal / Q000235:genetics / Q000627:therapeutic use*; D000915:Antibody Affinity; D005818:Genetic Engineering / Q000379:methods; D006801:Humans; D051379:Mice; D050997:Nanomedicine / Q000379:methods*; D036103:Nanotechnology / Q000379:methods; D009369:Neoplasms / Q000276:immunology* / Q000628:therapy*; D011993:Recombinant Fusion Proteins / Q000276:immunology / Q000627:therapeutic use
D000911:Antibodies, Monoclonal; D011993:Recombinant Fusion Proteins